(GNW) Genworth Financial - Overview

Sector: Financial Services | Industry: Insurance - Life | Exchange: NYSE (USA) | Market Cap: 3.279m USD | Total Return: 20.9% in 12m

Mortgage Insurance, Long-Term Care, Life Insurance, Annuities
Total Rating 30
Safety 18
Buy Signal -0.95
Insurance - Life
Industry Rotation: -10.1
Market Cap: 3.28B
Avg Turnover: 21.2M
Risk 3d forecast
Volatility25.8%
VaR 5th Pctl4.55%
VaR vs Median7.10%
Reward TTM
Sharpe Ratio0.69
Rel. Str. IBD39.9
Rel. Str. Peer Group32.5
Character TTM
Beta0.485
Beta Downside0.530
Hurst Exponent0.582
Drawdowns 3y
Max DD21.74%
CAGR/Max DD0.69
CAGR/Mean DD2.31
EPS (Earnings per Share) EPS (Earnings per Share) of GNW over the last years for every Quarter: "2021-06": 0.38, "2021-09": 0.46, "2021-12": 0.32, "2022-03": 0.25, "2022-06": 0.34, "2022-09": 0.31, "2022-12": 0.33, "2023-03": 0.12, "2023-06": 0.18, "2023-09": 0.09, "2023-12": -0.47, "2024-03": 0.19, "2024-06": 0.28, "2024-09": 0.19, "2024-12": 0.04, "2025-03": 0.12, "2025-06": 0.16, "2025-09": 0.04, "2025-12": 0.02, "2026-03": 0.28,
Last SUE: 0.80
Qual. Beats: 0
Revenue Revenue of GNW over the last years for every Quarter: 2021-06: 2041, 2021-09: 2011, 2021-12: 1913, 2022-03: 1851, 2022-06: 1855, 2022-09: 1810, 2022-12: 1873, 2023-03: 1826, 2023-06: 1875, 2023-09: 1800, 2023-12: 1870, 2024-03: 1844, 2024-06: 1733, 2024-09: 1844, 2024-12: 1722, 2025-03: 1778, 2025-06: 1727, 2025-09: 1873, 2025-12: 1493, 2026-03: 1723,
Rev. CAGR: -2.88%
Rev. Trend: -94.5%
Last SUE: 0.75
Qual. Beats: 0

Warnings

Fakeout Choppy Below Avwap Earnings

Tailwinds

No distinct edge detected

Description: GNW Genworth Financial

Genworth Financial, Inc. (GNW) is a Virginia-based financial services firm specializing in mortgage and long-term care (LTC) insurance. The company operates through its Enact segment, which provides private mortgage insurance and contract underwriting, and its Closed Block segment, which manages legacy insurance and annuity products. Its portfolio includes term and universal life insurance, fixed and variable annuities, and funding agreements distributed via direct sales and digital channels.

The long-term care insurance sector faces unique structural challenges due to rising healthcare costs and increased life expectancy, often requiring providers to seek regulatory approval for premium rate increases to maintain solvency. As a mortgage insurer, Genworth’s performance is closely linked to the U.S. housing market and credit default rates, as these products mitigate risk for lenders by covering losses when a borrower defaults. For a deeper look at these specific risk factors and valuation metrics, consider checking the latest data on ValueRay.

Headlines to Watch Out For
  • Enact mortgage insurance segment profitability and capital return to shareholders
  • Long-term care insurance rate increase approvals from state regulatory bodies
  • Interest rate fluctuations impacting investment income and insurance liability valuations
  • Legacy closed block insurance runoff and claims volatility affecting balance sheet
  • Housing market health and mortgage origination volume driving primary insurance growth
Piotroski VR-10 (Strict) 3.0
Net Income: 216.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.06 > 1.0
NWC/Revenue: 488.3% < 20% (prev 163.4%; Δ 324.8% < -1%)
CFO/TA 0.00 > 3% & CFO 384.0m > Net Income 216.0m
Net Debt (-8.81b) to EBITDA (511.0m): -17.25 < 3
Current Ratio: 3.39 > 1.5 & < 3
Outstanding Shares: last quarter (393.7m) vs 12m ago -6.90% < -2%
Gross Margin: 14.98% > 18% (prev 0.06%; Δ 1.49k% > 0.5%)
Asset Turnover: 7.83% > 50% (prev 8.11%; Δ -0.28% > 0%)
Interest Coverage Ratio: 4.02 > 6 (EBITDA TTM 511.0m / Interest Expense TTM 104.0m)
Altman Z'' 2.62
A: 0.38 (Total Current Assets 47.2b - Total Current Liabilities 13.9b) / Total Assets 86.8b
B: 0.02 (Retained Earnings 1.73b / Total Assets 86.8b)
C: 0.00 (EBIT TTM 418.0m / Avg Total Assets 87.0b)
D: 0.01 (Book Value of Equity 508.0m / Total Liabilities 76.9b)
Altman-Z'' = 2.62 = A
What is the price of GNW shares?

As of June 01, 2026, the stock is trading at USD 8.56 with a total of 1,841,572 shares traded.
Over the past week, the price has changed by -7.46%, over one month by -2.62%, over three months by +0.12% and over the past year by +20.90%.

Is GNW a buy, sell or hold?

Genworth Financial has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold GNW.

  • StrongBuy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the GNW price?
Analysts Target Price 11 28.5%
Genworth Financial (GNW) - Fundamental Data Overview as of 01 June 2026
Market Cap USD = 3.28b (3.28b USD * 1.0 USD.USD)
P/E Trailing = 16.4615
P/E Forward = 5.1125
P/S = 0.4496
P/B = 0.3719
P/EG = 0.3136
Revenue TTM = 6.82b USD
EBIT TTM = 418.0m USD
EBITDA TTM = 511.0m USD
Long Term Debt = 1.51b USD (from longTermDebt, last quarter)
 Short Term Debt = unknown (none)
 Debt = 1.51b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -8.81b USD (calculated: Debt 1.51b - CCE 10.3b)
Enterprise Value = 3.28b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 4.02 (Ebit TTM 418.0m / Interest Expense TTM 104.0m)
EV/FCF = 6.60x (Enterprise Value 3.28b / FCF TTM 497.0m)
FCF Yield = 15.16% (FCF TTM 497.0m / Enterprise Value 3.28b)
FCF Margin = 7.29% (FCF TTM 497.0m / Revenue TTM 6.82b)
Net Margin = 3.17% (Net Income TTM 216.0m / Revenue TTM 6.82b)
Gross Margin = 14.98% ((Revenue TTM 6.82b - Cost of Revenue TTM 5.79b) / Revenue TTM)
Gross Margin QoQ = 28.96% (prev 20.83%)
Tobins Q-Ratio = 0.04 (Enterprise Value 3.28b / Total Assets 86.8b)
Interest Expense / Debt = 6.89% (Interest Expense 104.0m / Debt 1.51b)
Taxrate = 27.93% (31.0m / 111.0m)
NOPAT = 301.3m (EBIT 418.0m * (1 - 27.93%))
Current Ratio = 3.24 (Total Current Assets 47.2b / Total Current Liabilities 14.6b)
Debt / Equity = 0.17 (Debt 1.51b / totalStockholderEquity, last quarter 8.81b)
Debt / EBITDA = -17.25 (Net Debt -8.81b / EBITDA 511.0m)
Debt / FCF = -17.74 (Net Debt -8.81b / FCF TTM 497.0m)
Total Stockholder Equity = 8.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.25% (Net Income 216.0m / Total Assets 86.8b)
RoE = 2.46% (Net Income TTM 216.0m / Total Stockholder Equity 8.79b)
RoCE = 4.06% (EBIT 418.0m / Capital Employed (Equity 8.79b + L.T.Debt 1.51b))
RoIC = 0.41% (NOPAT 301.3m / Invested Capital 72.7b)
WACC = 6.83% (E(3.28b)/V(4.79b) * Re(7.69%) + D(1.51b)/V(4.79b) * Rd(6.89%) * (1-Tc(0.28)))
Discount Rate = 7.69% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -5.71%
[DCF] Terminal Value 76.68% ; FCFF base≈478.6m ; Y1≈521.1m ; Y5≈649.0m
[DCF] Fair Price = 48.94 (EV 9.93b - Net Debt -8.81b = Equity 18.7b / Shares 383.0m; r=8.35% [WACC [floored]]; 5y FCF grow 10.20% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.80 | # QB: 0
Revenue Correlation: -94.45 | Revenue CAGR: -2.88% | SUE: 0.75 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.07 | Chg30d=N/A | Revisions=N/A | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.07 | Chg30d=N/A | Revisions=N/A | Analysts=1
EPS current Year (2026-12-31): EPS=0.41 | Chg30d=-2.38% | Revisions=-20% | GrowthEPS=+0.0% | GrowthRev=+0.0%
EPS next Year (2027-12-31): EPS=0.36 | Chg30d=-10.00% | Revisions=N/A | GrowthEPS=-12.2% | GrowthRev=+0.0%